WELLS FARGO & COMPANY/MN - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 55 filers reported holding ENZO BIOCHEM INC in Q1 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$1,796
-23.4%
1,282
+0.5%
0.00%
Q2 2023$2,346
-23.4%
1,275
+1.3%
0.00%
Q1 2023$3,061
-45.0%
1,259
-67.7%
0.00%
Q4 2022$5,566
+85.5%
3,892
+167.3%
0.00%
Q3 2022$3,000
+50.0%
1,456
+34.2%
0.00%
Q2 2022$2,000
-50.0%
1,085
+2.4%
0.00%
Q1 2022$4,0000.0%1,0600.0%0.00%
Q4 2021$4,0000.0%1,060
+0.1%
0.00%
Q3 2021$4,0000.0%1,059
-1.4%
0.00%
Q2 2021$4,000
-95.1%
1,074
-95.4%
0.00%
Q1 2021$81,000
-72.4%
23,302
-79.9%
0.00%
Q4 2020$293,000
-21.0%
116,150
-34.1%
0.00%
Q3 2020$371,000
-20.2%
176,168
-15.1%
0.00%
Q2 2020$465,000
-33.7%
207,455
-25.2%
0.00%
Q1 2020$701,000
-4.0%
277,164
-0.1%
0.00%
Q4 2019$730,000
-26.8%
277,469
+0.1%
0.00%
Q3 2019$997,000
-25.9%
277,092
-30.6%
0.00%
Q2 2019$1,345,000
+12.4%
399,051
-9.0%
0.00%
Q1 2019$1,197,000
+16.4%
438,383
+18.5%
0.00%
Q4 2018$1,028,000
-31.6%
369,850
+1.4%
0.00%
Q3 2018$1,502,000
-21.0%
364,612
-0.5%
0.00%
-100.0%
Q2 2018$1,901,000
+14.7%
366,364
+21.1%
0.00%
Q1 2018$1,658,000
-34.8%
302,617
-3.0%
0.00%
-100.0%
Q4 2017$2,542,000
-19.6%
311,826
+3.2%
0.00%0.0%
Q3 2017$3,163,000
+46.4%
302,072
+54.3%
0.00%0.0%
Q2 2017$2,161,000
-17.5%
195,730
-37.4%
0.00%0.0%
Q1 2017$2,618,000
+78.3%
312,813
+47.9%
0.00%0.0%
Q4 2016$1,468,000
+1967.6%
211,549
+1413.4%
0.00%
Q3 2016$71,000
-14.5%
13,9780.0%0.00%
Q2 2016$83,000
-8.8%
13,978
-30.2%
0.00%
Q1 2016$91,000
-20.2%
20,016
-21.4%
0.00%
Q4 2015$114,000
+5600.0%
25,466
+4283.1%
0.00%
Q3 2015$2,000
-88.9%
581
-90.1%
0.00%
Q2 2015$18,000
+12.5%
5,840
-0.4%
0.00%
Q1 2015$16,000
+23.1%
5,862
+104.3%
0.00%
Q4 2014$13,000
-27.8%
2,870
-14.5%
0.00%
Q3 2014$18,000
-25.0%
3,357
-23.6%
0.00%
Q2 2014$24,000
-76.7%
4,396
-82.2%
0.00%
Q1 2014$103,000
+836.4%
24,691
+593.8%
0.00%
Q4 2013$11,000
+266.7%
3,559
+135.5%
0.00%
Q3 2013$3,000
-25.0%
1,511
-33.0%
0.00%
Q2 2013$4,0002,2550.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q1 2023
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders